Elevance Health: Bearish Outlook Despite Q3 Gains

Elevance Health, a major healthcare benefits provider, has seen mixed performance recently. Despite a nine point two percent gain over the past three months, outpacing the Nasdaq, its stock has dropped over twenty-six percent from its peak in April. The companys stock has underperformed the broader Nasdaq market year-to-date and over the past year. Elevance reported a twelve percent revenue increase in its third-quarter results, but adjusted earnings per share dropped by nearly thirty percent. Analysts have a Moderate Buy rating on the stock, suggesting a twelve point one percent upside potential.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.